Stroke outcome in clinical trial patients deriving from different countries

Myzoon Ali, Sari Atula, Philip M W Bath, James Grotta, Werner Hacke, Patrick Lyden, John R. Marler, Ralph L Sacco, Kennedy R. Lees

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: Stroke incidence and outcome vary widely within and across geographical locations. We examined whether differences in index stroke severity, stroke risk factors, mortality, and stroke outcome across geographical locations remain after adjusting for case mix. METHODS: We analyzed 3284 patients from the Virtual International Stroke Trials Archive (VISTA). We used logistic regression to examine the incidence of mild index stroke, functional, and neurological outcomes after accounting for age, medical history, year of trial recruitment, and initial stroke severity in the functional and neurological outcome analyses. We examined mortality between geographical regions using a Cox proportional hazards model, accounting for age, initial stroke severity, medical history, and year of trial recruitment. RESULTS: Patients enrolled in the USA and Canada had the most severe index strokes. Those recruited in Austria and Switzerland had the best functional and neurological outcomes at 90 days (P<0.05), whereas those enrolled in Germany had the worst functional outcome at 90 days (P≤0.013). Patients enrolled in Austria, Switzerland, Belgium, Netherlands, Finland, Germany, Greece, Israel, Spain, and Portugal had a significantly better survival rate when compared with those enrolled in USA and Canada. Patients enrolled in trials after 1998 had more severe index strokes, with no significant difference in outcome compared with those enrolled before 1998. CONCLUSION: We identified regional variations in index stroke severity, outcome, and mortality for patients enrolled in ischemic stroke clinical trials over the past 13 years that were not fully explained by case mix. Index stroke severity was greater in patients enrolled after 1998, with no significant improvement in outcomes compared to those enrolled before 1998.

Original languageEnglish
Pages (from-to)35-40
Number of pages6
JournalStroke
Volume40
Issue number1
DOIs
StatePublished - Jan 1 2009

Fingerprint

Stroke
Clinical Trials
Austria
Diagnosis-Related Groups
Switzerland
Canada
Germany
Mortality
Portugal
Greece
Belgium
Incidence
Israel
Finland
Proportional Hazards Models
Netherlands
Spain
Survival Rate
Logistic Models

Keywords

  • Acute care
  • Clinical trials
  • Database
  • Epidemiology
  • Outcomes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Advanced and Specialized Nursing
  • Medicine(all)

Cite this

Ali, M., Atula, S., Bath, P. M. W., Grotta, J., Hacke, W., Lyden, P., ... Lees, K. R. (2009). Stroke outcome in clinical trial patients deriving from different countries. Stroke, 40(1), 35-40. https://doi.org/10.1161/STROKEAHA.108.518035

Stroke outcome in clinical trial patients deriving from different countries. / Ali, Myzoon; Atula, Sari; Bath, Philip M W; Grotta, James; Hacke, Werner; Lyden, Patrick; Marler, John R.; Sacco, Ralph L; Lees, Kennedy R.

In: Stroke, Vol. 40, No. 1, 01.01.2009, p. 35-40.

Research output: Contribution to journalArticle

Ali, M, Atula, S, Bath, PMW, Grotta, J, Hacke, W, Lyden, P, Marler, JR, Sacco, RL & Lees, KR 2009, 'Stroke outcome in clinical trial patients deriving from different countries', Stroke, vol. 40, no. 1, pp. 35-40. https://doi.org/10.1161/STROKEAHA.108.518035
Ali M, Atula S, Bath PMW, Grotta J, Hacke W, Lyden P et al. Stroke outcome in clinical trial patients deriving from different countries. Stroke. 2009 Jan 1;40(1):35-40. https://doi.org/10.1161/STROKEAHA.108.518035
Ali, Myzoon ; Atula, Sari ; Bath, Philip M W ; Grotta, James ; Hacke, Werner ; Lyden, Patrick ; Marler, John R. ; Sacco, Ralph L ; Lees, Kennedy R. / Stroke outcome in clinical trial patients deriving from different countries. In: Stroke. 2009 ; Vol. 40, No. 1. pp. 35-40.
@article{dba8e22057d249e4aca4fd1d7d3ccf62,
title = "Stroke outcome in clinical trial patients deriving from different countries",
abstract = "BACKGROUND AND PURPOSE: Stroke incidence and outcome vary widely within and across geographical locations. We examined whether differences in index stroke severity, stroke risk factors, mortality, and stroke outcome across geographical locations remain after adjusting for case mix. METHODS: We analyzed 3284 patients from the Virtual International Stroke Trials Archive (VISTA). We used logistic regression to examine the incidence of mild index stroke, functional, and neurological outcomes after accounting for age, medical history, year of trial recruitment, and initial stroke severity in the functional and neurological outcome analyses. We examined mortality between geographical regions using a Cox proportional hazards model, accounting for age, initial stroke severity, medical history, and year of trial recruitment. RESULTS: Patients enrolled in the USA and Canada had the most severe index strokes. Those recruited in Austria and Switzerland had the best functional and neurological outcomes at 90 days (P<0.05), whereas those enrolled in Germany had the worst functional outcome at 90 days (P≤0.013). Patients enrolled in Austria, Switzerland, Belgium, Netherlands, Finland, Germany, Greece, Israel, Spain, and Portugal had a significantly better survival rate when compared with those enrolled in USA and Canada. Patients enrolled in trials after 1998 had more severe index strokes, with no significant difference in outcome compared with those enrolled before 1998. CONCLUSION: We identified regional variations in index stroke severity, outcome, and mortality for patients enrolled in ischemic stroke clinical trials over the past 13 years that were not fully explained by case mix. Index stroke severity was greater in patients enrolled after 1998, with no significant improvement in outcomes compared to those enrolled before 1998.",
keywords = "Acute care, Clinical trials, Database, Epidemiology, Outcomes",
author = "Myzoon Ali and Sari Atula and Bath, {Philip M W} and James Grotta and Werner Hacke and Patrick Lyden and Marler, {John R.} and Sacco, {Ralph L} and Lees, {Kennedy R.}",
year = "2009",
month = "1",
day = "1",
doi = "10.1161/STROKEAHA.108.518035",
language = "English",
volume = "40",
pages = "35--40",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Stroke outcome in clinical trial patients deriving from different countries

AU - Ali, Myzoon

AU - Atula, Sari

AU - Bath, Philip M W

AU - Grotta, James

AU - Hacke, Werner

AU - Lyden, Patrick

AU - Marler, John R.

AU - Sacco, Ralph L

AU - Lees, Kennedy R.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - BACKGROUND AND PURPOSE: Stroke incidence and outcome vary widely within and across geographical locations. We examined whether differences in index stroke severity, stroke risk factors, mortality, and stroke outcome across geographical locations remain after adjusting for case mix. METHODS: We analyzed 3284 patients from the Virtual International Stroke Trials Archive (VISTA). We used logistic regression to examine the incidence of mild index stroke, functional, and neurological outcomes after accounting for age, medical history, year of trial recruitment, and initial stroke severity in the functional and neurological outcome analyses. We examined mortality between geographical regions using a Cox proportional hazards model, accounting for age, initial stroke severity, medical history, and year of trial recruitment. RESULTS: Patients enrolled in the USA and Canada had the most severe index strokes. Those recruited in Austria and Switzerland had the best functional and neurological outcomes at 90 days (P<0.05), whereas those enrolled in Germany had the worst functional outcome at 90 days (P≤0.013). Patients enrolled in Austria, Switzerland, Belgium, Netherlands, Finland, Germany, Greece, Israel, Spain, and Portugal had a significantly better survival rate when compared with those enrolled in USA and Canada. Patients enrolled in trials after 1998 had more severe index strokes, with no significant difference in outcome compared with those enrolled before 1998. CONCLUSION: We identified regional variations in index stroke severity, outcome, and mortality for patients enrolled in ischemic stroke clinical trials over the past 13 years that were not fully explained by case mix. Index stroke severity was greater in patients enrolled after 1998, with no significant improvement in outcomes compared to those enrolled before 1998.

AB - BACKGROUND AND PURPOSE: Stroke incidence and outcome vary widely within and across geographical locations. We examined whether differences in index stroke severity, stroke risk factors, mortality, and stroke outcome across geographical locations remain after adjusting for case mix. METHODS: We analyzed 3284 patients from the Virtual International Stroke Trials Archive (VISTA). We used logistic regression to examine the incidence of mild index stroke, functional, and neurological outcomes after accounting for age, medical history, year of trial recruitment, and initial stroke severity in the functional and neurological outcome analyses. We examined mortality between geographical regions using a Cox proportional hazards model, accounting for age, initial stroke severity, medical history, and year of trial recruitment. RESULTS: Patients enrolled in the USA and Canada had the most severe index strokes. Those recruited in Austria and Switzerland had the best functional and neurological outcomes at 90 days (P<0.05), whereas those enrolled in Germany had the worst functional outcome at 90 days (P≤0.013). Patients enrolled in Austria, Switzerland, Belgium, Netherlands, Finland, Germany, Greece, Israel, Spain, and Portugal had a significantly better survival rate when compared with those enrolled in USA and Canada. Patients enrolled in trials after 1998 had more severe index strokes, with no significant difference in outcome compared with those enrolled before 1998. CONCLUSION: We identified regional variations in index stroke severity, outcome, and mortality for patients enrolled in ischemic stroke clinical trials over the past 13 years that were not fully explained by case mix. Index stroke severity was greater in patients enrolled after 1998, with no significant improvement in outcomes compared to those enrolled before 1998.

KW - Acute care

KW - Clinical trials

KW - Database

KW - Epidemiology

KW - Outcomes

UR - http://www.scopus.com/inward/record.url?scp=60549106053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549106053&partnerID=8YFLogxK

U2 - 10.1161/STROKEAHA.108.518035

DO - 10.1161/STROKEAHA.108.518035

M3 - Article

C2 - 18927457

AN - SCOPUS:60549106053

VL - 40

SP - 35

EP - 40

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 1

ER -